PPARGC1A and Alzheimer disease: For example, Wu et al. (113) utilized integrated proteomics and metabolomics to reveal that the Danggui Shaoyao San formula may exert therapeutic effects on AD by promoting the EM regulation of the GSK3β/PGC1α signaling pathway.